Hide Board Information

Show Board Information

Jpmrgn Pfd Ser J JPM-I

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/29/2012 7:30:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Jpmrgn Pfd Ser J (NYSE: JPM-I) Stock Message Board

1. JPM-I Company Profile

    

2. JPM-I Time & Sales

    

3. JPM-I Recent News

    

4. JPM-I Filings

    

5. JPM-I Financials

    

6. JPM-I Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Jpmrgn Pfd Ser J JPM-I

Recent Articles

• ElectronX Chooses Connamara's EP3 Platform for Energy Exchange
• MGM Resorts Plans Strategic Sale of Northfield Park Operations
• AllianceBernstein Unveils Enhanced Secure Income Options
• BTQ Technologies Pioneer Steps for Quantum-Safe Bitcoin Security
• Zenos Health Reveals Innovative Keynote Speakers for Wellness Summit
• GAC Group Unveils AION V, Aiming High in European EV Scene
• Power Knot's LFC-IX Biodigester Machines Gain Trusted Certification
• Cineplex Completes Major Sale to Focus on Core Business Growth
• TNL Mediagene Partners with Geniee to Enhance Ad Solutions
• C4 Therapeutics Secures $125 Million for Clinical Trials and Growth
• IBM Introduces Innovative AI Agents for Enhanced Efficiency
• Compass Inc. to Unveil Financial Performance in November
• Transformative Virtual Weigh Stations Set New Standards in Safety
• Anywhere Real Estate Inc. Set to Share Q3 Financial Insights
• Hamilton Zanze's Strategic Investment in Village of the Pines
• Exploring Dividend-Yielding Industrial Stocks for Investors
• Blue Sky Uranium Completes Significant Survey at Amarillo Projects
• Aduro Clean Technologies Achieves Milestones in Q1 2026 Results
• SaaS Capital Launches $100 Million Fund for Innovative Companies
• Commercial Metals Company: Strong Fourth Quarter Performance Revealed
• Halloween Specials: 7-Eleven's BOGO Treats and Exciting Offers
• Zitro Shines Bright at the Grand G2E Las Vegas Showcase
• Ligand Pharmaceuticals' Upcoming Investor Day Promises Insights
• Chicago Atlantic Real Estate Finance Prepares Q3 Earnings Update
• First Advantage to Discuss Q3 2025 Financial Outcomes Soon
• BPGbio's Groundbreaking Glioblastoma Data Unveiled at ESMO 2025
• ConnectOne Bancorp Plans Q3 Conference Call for Investors
• Caliber Invests $2 Million in Chainlink Tokens for Growth
• Plug Power's CEO Highlights Hydrogen Opportunities at Summit
• Conavi Medical: Exciting Presentation at Planet MicroCap Showcase
• Foghorn Therapeutics Shares Groundbreaking Developments in Oncology
• Cellectis Showcases Gene Editing Breakthroughs and Future Goals
• SINTX Enhances Antipathogenic Technologies with New Patent
• Draganfly Teams with Drone Nerds to Enhance Drone Offerings
• I-care Partners with DimoMaint to Revolutionize Equipment Maintenance
• Apellis Pharmaceuticals Plans Exciting Discussion on Q3 Results
• McDermott Achieves Milestone with TotalEnergies Subsea Project
• Seneca Bancorp, Inc. Advances to OTCQX, Enhancing Investor Access
• Celerant Introduces Geo-Fencing for Enhanced Retail Experience
• Insights into Agios Pharmaceuticals' Upcoming Financial Call
• Creative Realities Sets Stage for Growth with Major Acquisition
• TNL Mediagene Partners with Geniee for Innovative Advertising Solutions
• C4 Therapeutics Secures $125 Million for Clinical Advancements
• Praxis Precision Medicines Celebrates Major Progress in ET Treatment
• Honeywell's New Chapter: The Spin-Off of Solstice Advanced Materials
• NGEx Minerals Set for Major Spin-out, Appoints New CEO for LunR
• GameAbove Sports Launches Scholarship for Future Soccer Stars
• Thesis Gold Expands Leadership Team with Strategic Appointments
• Blue Sky Uranium Explores Key Anomaly at Ivana Gap Target
• Rokmaster's Promising Assay Results and New Drill Permits